Integra LifeSciences Reports First Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Integra LifeSciences (IART) Misses Q1 EPS by 16c
May 7, 2020 6:41 AM EDTIntegra LifeSciences (NASDAQ: IART) reported Q1 EPS of $0.48, $0.16 worse than the analyst estimate of $0.64. Revenue for the quarter came in at $354.3 million versus the consensus estimate of $363.24 million.
2020 Full-Year Outlook
Given the existing uncertainty related to COVID-19, the Companys guidance for the full-year 2020, issued... More
